0 results available. Select is focused ,type to refine list, press Down to open the menu,
Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...
The following section summarizes insights on Inozyme Pharma Inc's EPS Forecast (FINBOX):
We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EPS Forecast (FINBOX) in the forecast category include:
Forecasted earnings per share (EPS).
The chart above depicts the distribution of eps forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,020 companies were considered in this analysis, and 1,945 had meaningful values. The average eps forecast (finbox) of companies in the sector is -0.20 with a standard deviation of 3.33.
Inozyme Pharma Inc's EPS Forecast (FINBOX) of -2.56 ranks in the 12.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,025 |
| Included Constituents | 1,945 |
| Min | -16.20 |
| Max | 16.37 |
| Median | -0.043 |
| Mean | -0.20 |
| Standard Deviation | 3.33 |
You can find companies with similar eps forecast (finbox) using this stock screener.